5%) in our patient cohort, although being non-significant due to the small cohort size but showing a clear trend towards tigecycline therapy.
← all excerpts
Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis.
1
—
—